MEDAKMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 145,507 | 172,823 | 177,018 | 219,628 | 288,788 | 324,744 | 394,156 | 500,984 |
| Profit before tax | -7,964 | -6,034 | 39,515 | 23,393 | 61,154 | 81,628 | 99,088 | 96,490 |
| Net profit | -8,006 | -6,231 | 39,377 | 23,283 | 60,945 | 81,461 | 98,931 | 81,036 |
| Equity | -122,560 | -121,330 | -81,954 | -58,671 | 2,274 | 83,734 | 176,260 | 101,106 |
| Liabilities | 154,592 | 163,524 | 159,378 | 145,212 | 147,027 | 64,468 | 66,093 | 69,718 |
| Non-current assets | 5,372 | 4,069 | 11,870 | 13,815 | 20,340 | 18,323 | 30,907 | 53,023 |
| Current assets | 26,660 | 38,125 | 65,554 | 72,726 | 128,961 | 129,879 | 211,446 | 117,801 |
| Total assets | 32,032 | 42,194 | 77,424 | 86,541 | 149,301 | 148,202 | 242,353 | 170,824 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 37,955 | 47,467 | 85,954 |
| Social insurance contributions | - | - | - | - | - | 45,655 | 52,112 | 77,370 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.7% | +18.8% | +2.4% | +24.1% | +31.5% | +12.5% | +21.4% | +27.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -25.0% | -14.8% | 50.9% | 26.9% | 40.8% | 55.0% | 40.8% | 47.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 2680.1% | 97.3% | 56.1% | 80.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -5.5% | -3.6% | 22.2% | 10.6% | 21.1% | 25.1% | 25.1% | 16.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -5.5% | -3.5% | 22.3% | 10.7% | 21.2% | 25.1% | 25.1% | 19.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 64.7 | 0.8 | 0.4 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,288 | 10,915 | 11,180 | 13,945 | 19,253 | 22,017 | 24,256 | 26,838 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDAKMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.01 |
MEDAKMA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-15 | 2026-01-16 | 8.62 |
| 2025-04-04 | 2025-04-04 | 4654.56 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDAKMA, UAB (code 300151037) is a Private Limited Liability Company engaged in physiotherapy activities. In 2025, the company generated revenue of €501.0K, up 27.1% year on year and 54.3% over two years. Net profit for 2025 was €81.0K, compared with €98.9K in 2024 and €81.5K in 2023, showing that profitability remained positive but weakened from the prior year as the profit margin declined to 16.2% from 25.1% in both 2023 and 2024. The balance sheet in 2025 shows total assets of €170.8K, equity of €101.1K and liabilities of €69.7K. Compared with 2024, assets and equity decreased, while liabilities increased slightly. Long-term assets rose to €53.0K and short-term assets were €117.8K. Key ratios indicate efficient asset use and a solid return profile, with asset turnover of 2.93x, debt-to-equity of 0.69 and an equity ratio of 59.2%. Revenue per employee was €27.8K and profit per employee €4.5K in 2025.